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Interferons (IFN) are a  group of polypeptides that have in common the ability to 
induce in cells resistance to a  broad spectrum of viral infections.  Immune or y-IFN 
differs in several distinct ways from a-IFN (leukocyte derived) and fl-IFN (fibroblast 
derived) on the basis of both biologic and physicochemical criteria (1-3). Leukocyte 
and fibroblast IFN are released when cells become infected by virus; immune IFN, on 
the  other  hand,  is  produced  by  lymphoid  cells  during  the  course  of an  immune 
response. There are a  number of correlations between the stimulation of T  cells and 
the  release  of  immune  IFN.  For  example,  culturing  lymphoid  cells  with  T  cell 
mitogens  or  with  antigens  that  stimulate  a  strong  T  cell  response  leads  to  the 
production of immune IFN (4-9). Recently, there have been reports that a human T 
cell line  (1(3) and a  number of murine T  cell clones  (11)  release immune IFN upon 
culture with PHA or Con  A. Although  these cell lines were probably of the T  cell 
lineage, they lacked any functionally defined T  cell characteristics. 
Kirchner et al.  (8) reported the provocative finding that in murine mixed lympho- 
cyte culture  (MLC), differences in class I  (H-2K or D)  antigens  induced  more IFN 
production  than  differences  in  the  I  region  or  the  Mls  locus.  This  was  true  even 
though I region or Mls differences were better stimulators of T  cell proliferation. This 
finding suggested to us that immune IFN may be released by cytotoxic T lymphocytes 
(CTL) that are H-2K, D region specific. Additionally, treatment of antigen-stimulated 
spleen cells with anti-Lyt-2,3 antisera plus complement ((2') has been shown to greatly 
reduce the level of IFN, although in these experiments anti-immunoglobulin, anti-Ia, 
and anti-Lyt-1  sera also had the same effect  (12).  Moreover, a  correlation has been 
demonstrated between IFN release and the development of CTL activity in MLC in 
which  the responders came from primed or normal mice (9).  Farrar and colleagues 
(13) have pointed to the correlation between immune IFN release and CTL activation, 
and we have also found a strong correlation between CTL activity and IFN production 
(unpublished observations). 
In  this  communication,  we  show  that  clones  of  murine  antigen-specific,  H-2- 
restricted CTL release high levels of immune IFN when they are co-cultured with the 
mitogen Con A  or with allogeneic cells presenting antigen.  IFN release in the latter 
case is antigen specific and H-2 restricted. These results add a new, important aspect 
to our understanding  of T  cell immunity to foreign membrane antigens in showing 
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that CTL can deliver a  "one-two punch" at a local site: death to a target cell and the 
local release of immune IFN. 
Materials and Methods 
Mice.  BALB/cAnN (H-2d), BALB.B (H-2b), and (B10.BR × B10.D2)F1 (H-2  k × H-2  d) mice 
were bred at the Center for Cancer Research, Massachusetts Institute of Technology. B 10.D2/ 
nSnJ and B10.BR/SgSnJ mice were purchased from The Jackson Laboratory, Bar Harbor, 
ME. All animals were used at 8-20 wk of age. 
Antisera Treatment.  Thy-1 positive cells were removed from normal spleen cells by treatment 
with two monoclonal anti-Thy-1 antibodies followed  by rabbit C'. Normal spleen cells were 
suspended at  10  7 cells/ml in Hanks' balanced salt solution containing ascites  fluid from mice 
bearing hybridoma clone 13.4 (14) plus T24 culture supernatant (15) at final dilutions of 1:100 
and  1:50, respectively.  After 30 min at 4°C, cells were  resuspended at 5 ×  106/ml  in a  1:20 
dilution of a selected  rabbit C' and incubated for 45 min at 37°C. 
Cloned CTL.  The history and specificity of the crl5 cloned CTL line has been described 
(16).  The  cells  derive  from  a  (BI0.BR  ×  B10.D2)F1  mouse and  are  specific  for  a  BALB 
background minor histocompatibility antigen plus H-2D  a. The cells were cloned by limiting 
dilution (at 0.3 cells/well) and maintained as described by Glasebrook and Fitch (17) by weekly 
subculture in medium containing IL-2 plus irradiated BALB/c spleen cells. The medium used 
was RPMI 1640 (Microbiological Associates, Walkersville, MD) containing  5% fetal calf serum, 
5 ×  10  -5 M 2-mercaptoethanol (MLC medium), supplemented with 50 mM a-methyl manno- 
side,  and  20%  medium  from  spleen  cells  (5  ×  10S/ml)  cultured  for  24  h  with  2  /tg/ml 
concanavalin A (Con A). 
The spleen Con A supernatant can be replaced by the supernatant from AOFS 21.10.9 T 
hybridoma ceils cultured with 10 #g/ml Con A for 24 h (18). Most of the Con A was removed 
from AOFS Con A supernatant (AOFS Sup) by adsorption to Sepharose 4B coupled with p- 
amino-phenyl-a-D-mannopyranoside  (D. C. Parker, personal communication). 
Assay for Cytotoxic Activity.  crl5 cells that had been subcultured in medium with AOFS Sup 
without stimulator cells  for 5 d  were titrated against a  constant number (4  ×  104) of 51Cr- 
sodium chromate lipopolysaccharide-induced B cell blasts from various mouse strains (16). 
IFNProduction.  cr15 cells were harvested 7-12 d after the previous subculture and washed 
twice in RPMI 1640 medium containing 5% FCS. 2 ×  105 to 5 ×  10  s cells/ml were cultured in 
2 ml volumes in Costar wells  (Costar,  Data Packaging, Cambridge, MA)  in MLC medium 
supplemented with 20% AOFS Sup with 2 ×  106/ml  irradiated (1,300 rad), T  cell-depleted 
spleen cells, or Con A. Usually, after 2 d incubation at 37°C, the cultures were harvested, and 
centrifuged at  500 g for  10 min. The supernatants were passed through a  0.2/tm filter and 
stored frozen.  0.2 ml cultures in Costar 3596 wells were pulsed on day 2-3 for 4 h with 2/~Ci 
[ZH]thymidine for 4 h to assess the rate of DNA synthesis. 
IFNAssay.  IFN activity was determined in a conventional  cytopathic effect (CPE) inhibition 
assay  of vesicular stomatitis virus  (VSV)  on  L  cells  (1). L  cells  were  seeded  into 96-well 
microtiter plates (Costar 3596) in a volume of 100 #l/well. To this was added 50 pl of serially 
diluted test supernatants. 24 h  later, 50/~1 of 200 TCIDs0 VSV was added to each well. 48 h 
post-infection, the tissue monolayer was scored visually for virus-induced CPE. The IFN titer 
is defined as the reciprocal of the highest dilution showing at least  50% inhibition of CPE in 
triplicate cultures. 
IFN Neutralization.  Supernatant from antigen or mitogen-induced crl5 cells was dialyzed 
for 24 h against 0.1 M glycine-HCl, 0.15 M  NaCI, pH 2.0 buffer, followed by dialysis for 48 h 
against  phosphate-buffered  saline,  pH  7.2, and  RPMI  1640 medium.  Rabbit  anti-mouse 
immune IFN ~erum was generously provided by Dr. Howard M. Johnson, University of Texas, 
Galveston, TX, and was used according to his protocol (19). Briefly, diluted antiserum (1:30) 
was mixed with an equal volume of serially diluted IFN supernatant and incubated at room 
temperature for  1 h. 50/~1 of each sample was then added to L cell monolayers and tested for 
VSV inhibition as described above. 
Results 
Characteristics of Cloned CTL.  Clones of CTL isolated and maintained with antigen 1200  KLEIN ET AL.  BRIEF  DEFINITIVE REPORT 
TABLE  I 
H-2a-restricted Cytotoxic Activity of cr l5 CTL 
Target cell 
Percent specific lysis at CTL/ 
target ratio 
10:1  1:1 
(B10.BR ×  B10.D2)F1, H-2k/H-2  d  -5  -2 
B 10.D2, H-2  d  -4  0 
BALB/c, H-2  a  38  22 
BALB.B, H-2  b  -2  -  1 
(BALB.B ×  B10.D2)F~,  H-2b/H-2  a  20  15 
crl5 CTL were assayed for 4 h for lysis of 51Cr-labeled, 3-d LPS-induced spleen cells from 
the various strains listed. 
TABLE II 
Production of Immune IFN by cr  l 5 CTL in Response to Antigen Stimulation 
IFN Titer following treatment 
Cells cultured  Anti-im-  [3H]TdR 
None  Dialysis  Dialysis  incorporation 
pH 7.2  pH 2.0  muse 
IFN 
Experiment 1  BALB.Bz alone  <6  ND*  ND  ND  40 
BALB/cz alone  <6  ND  ND  ND  520 
crl5 plus BALB.B~  96  96  <6  ND  2,156 
crl5 plus BALB/cz  768  768  12  ND  15,440 
Experiment 2  cr 15 alone  <6  ND  ND  ND  1,440 
erl5 plus BI0.D2x  96  ND  ND  ND  800 
¢r15 plus BALB/cx  3,072  ND  ND  96  6,660 
2.6 ×  105 erl5 eells/ml (experiment 1) or 5 X  106 crl5 cells/ml (experiment 2) were cultured in 20% AOFS Sup 
eontmaing medium with 2 ×  10n/ml spleen cells that had been treated with anti-Thy 1 plus C' and irradiated. 
Sup~'natlmu ~t~  harvested on day 2 of culture for the IFN assay. Triplicate 0.2-ml cultures were pulsed with 
[SH]th~midine on day 3. Stimulator cells, when cultured with Con A, 2 #g/ml, produced no detectable amounts 
of I1~ (<6), 
* Not done. 
and growth factors remain  dependent  on both antigenic stimulation and  IL-2 for 
optimum growth. The cytotoxic specificity of crl5  (B10.BR ×  B10.D2)F1  CTL for a 
BALB background minor histocompatibility antigen recognized in the context of H- 
2  d is illustrated by the data in Table I: the CTL lyse BALB/c(H-2  d) targets, but not 
BALB.B(H-2  ~)  targets,  because  of H-2  restriction, or B10.D2(H-2 d)  targets, which 
lack the foreign minor antigen; they do lyse the (BALB.B ×  B10.D2)F1  target, which 
carries the BALB minor histocompatibility antigen plus H-2  d (16).  The crl5  CTL 
used in the following experiments were typed with a battery of antisera and shown to 
be  100% sensitive to lysis with anti-H-2  d, anti-H-2  k, anti-Thy-l.2, and anti-Lyt-2.2 
antibodies and C' (data not shown). 
IFN Production by crl5 in Response  to Antigens.  When cultured in the presence of T 
cell-depleted, irradiated allogeneic stimulator cells in IL-2 supplemented medium free 
of IFN (i.e., AOFS Sup), crl5 cells were found to make significant levels of IFN in 
2-d cultures (Table II). IFN produced by these cultures was of the immune type based 
on its sensitivity to pH 2.0 and on its inactivation by anti-mouse immune IFN serum 
(>98% loss of IFN activity in each case),  crl5 cultured alone, i.e.,  in the absence of 
antigen but in IL-2 supplemented medium, as above, failed to produce IFN. Addi- 
tionally, erlS, when cultured with semisyngeneic cells  or H-2 mismatched BALB.B 
cells, produced substantially less immune IFN (1:96)  than that made in response to 
alloantigenic stimulation (1:768 and  1:3,072).  The possibility that immune IFN was 
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TABLE III 
Con A Induced Release of lFN  from cr  l 5 CTL 
IFN Titer 
Cells cultured  Dose of Con A  Anti-im-  [ZH]TdR 
No treat-  mune  incorporation 
ment  IFN 
cr  15  0  <6  ND*  1,440 
crl5  0.4/xg/ml  6,144  ND  150 
crl5  1.0 p,g/ml  12,288  ND  160 
crl5  2.0/~g/ml  12,288  384  t 18 
crl5  4.0/~g/ml  6,144  ND  110 
crl5  8.0/~g/ml  1,530  ND  122 
BALB/c spleen,  2.0/tg/ml  768  48  ND 
5 ×  10S/ml 
crl5 cells were washed twice in medium lacking IFN and cultured at 5 ×  105/ml with 
the indicated dose of Con A  in  MLC  medium supplemented with 20% AOFS Sup. 
Culture medium was collected on day 2 for the IFN assay. 
* Not done. 
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effectively ruled out because Con A  stimulation of these cells alone failed to induce 
IFN production; Con A is known to promote IFN production in normal whole spleen 
cell cultures (see Table III). Thus, the cloned CTL line described here makes immune 
IFN in an antigen-dependent fashion with the same specificity that regulates its CTL 
activity. 
As previously described, crl5 require both antigen-specific stimulation and IL-2 for 
growth.  In both sets of experiments (Table II), thymidine incorporation as well as 
IFN production was maximal in crl5 cultures stimulated with antigen-bearing cells. 
Effect of Con A  Stimulation on IFN Production by cr  l 5.  crl5 were tested for their ability 
to make immune  IFN  in  the absence of antigen  when  stimulated  with  the T  cell 
mitogen, Con A. Cells cultured with Con A  produced high levels of IFN in a  dose- 
dependent  fashion;  in the same experiments there was a  fourfold greater IFN titer 
(12,288 vs. 3,072) in Con A-stimulated cr15 cells as compared with antigen-stimulated 
cells.  The ability of crl5 cells to make IFN upon addition of Con A further confirms 
the source of IFN to be the CTL themselves, because no additional cells were added. 
Of interest in this experiment was the sharp reduction in proliferative activity by Con 
A-stimulated crl5 cells, despite large amounts of secreted IFN. 
The IFN activity induced by Con A  was  also shown  to be >94%  susceptible  to 
overnight dialysis at pH 2.0 (data not shown) and treatment with anti-immune IFN 
serum. The IFN titer of a typical 24-h Con A induced spleen cell supernatant is also 
shown in Table III. Finally, we have shown that an alloreactive, cloned CTL line, G4, 
derived from a BALB.B mouse, specific for H-2  d antigens, also releases IFN in response 
to Con A or antigen stimulation. 
Discussion 
The results presented here demonstrating antigen- or mitogen-induced release of 
immune  IFN  by cloned CTL lines  explain  the  correlations  that  have been  noted 
between CTL stimulation and IFN production (7-9,  13, 20). In what way immune 
IFN  participates  in  CTL function remains  to  be  determined.  However, there  are 
several possible ways in which IFN could be of importance. IFN could contribute to 
the killing of target cells recognized by the CTL, i.e., it could provide the "lethal-hit" 
to the target. Immune IFN may also be an interleukin which, when released by CTL, 1202  KLEIN ET AL.  BRIEF  DEFINITIVE REPORT 
acts  in  some  immunoregulatory  capacity on  other  immune  cells  responding  to  the 
same  antigen;  there  is  a  substantial  body of information  supporting  this  role  for 
immune IFN (1,  3).  However, the most straightforward  interpretation  of the finding 
that CTL release IFN on binding antigen is that IFN contains the spread of antigen. 
For example, CTL that recognize and kill virus-infected cells would help prevent the 
spread of infection if, in addition, they released IFN at the local site of infection. IFN 
may also inhibit tumor growth or enhance the activity of other killer mechanisms at 
the site ofa CTL-target recognition event  (21, 22). Finally, it should be kept in mind 
that our results demonstrating IFN production by CTL do not rule out the possibility 
that immune IFN is made by other lymphoid cells as well. 
Summary 
Interferon  (IFN)  was found to be secreted  by cloned  lines of murine  cytotoxic T 
lymphocytes  in  response  to  mitogenic  or  antigen  specific  stimulation.  The  IFN 
produced was shown to be of the immune type based on its sensitivity to pH 2.0 and 
on the ability of an antiserum  to immune IFN to neutralize the antiviral activity. 
Note added in proof Since submission of this manuscript, a report of antigen-induced 
secretion of IFN by a  virus-specific CTL line has appeared  (23). 
Received  for publication 28 December 1981. 
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